{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/antacids-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926818",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926818_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"acalabrutinib\" outputclass=\"int-drug\">acalabrutinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   acalabrutinib .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acalabrutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926819",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926819_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"alendronate\" outputclass=\"int-drug\">alendronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronate</xref></ph> should be taken at least 30 minutes before antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   alendronate .  Manufacturer advises  alendronate  should be taken at least 30 minutes before antacids .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alendronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926820",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926820_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"aspirin\" outputclass=\"int-drug\">aspirin</ph> <ph outputclass=\"int-substanceQualifier\">(high-dose)</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   aspirin   (high-dose) .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aspirin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926821",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926821_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"atazanavir\" outputclass=\"int-drug\">atazanavir</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"atazanavir\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/atazanavir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3800\">atazanavir</xref></ph> should be taken 2 hours before or 1 hour after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   atazanavir .  Manufacturer advises  atazanavir  should be taken 2 hours before or 1 hour after antacids .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atazanavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926822",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926822_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Baloxavir marboxil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926823",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926823_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"bictegravir\" outputclass=\"int-drug\">bictegravir</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   bictegravir .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bictegravir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926824",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926824_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"bosutinib\" outputclass=\"int-drug\">bosutinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"bosutinib\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/bosutinib.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP33920\">bosutinib</xref></ph> should be taken at least 12 hours before antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   bosutinib .  Manufacturer advises  bosutinib  should be taken at least 12 hours before antacids .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bosutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926825",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926825_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"cabotegravir\" outputclass=\"int-drug\">cabotegravir</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"cabotegravir\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/cabotegravir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP223423\">cabotegravir</xref></ph> should be taken 4 hours before or 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the concentration of   oral   cabotegravir .  Manufacturer advises  cabotegravir  should be taken 4 hours before or 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cabotegravir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926826",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926826_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ceritinib\" outputclass=\"int-drug\">ceritinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   ceritinib .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ceritinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926827",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926827_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"chloroquine\" outputclass=\"int-drug\">chloroquine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   chloroquine .  Manufacturer advises separate administration by at least 4 hours .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chloroquine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926828",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926828_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlorpromazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926829",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926829_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"cholic acid\" outputclass=\"int-drug\">cholic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 5 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   cholic acid .  Manufacturer advises separate administration by 5 hours .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cholic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926830",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926830_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ciprofloxacin\" outputclass=\"int-drug\">ciprofloxacin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"ciprofloxacin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ciprofloxacin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3665\">ciprofloxacin</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   ciprofloxacin .  Manufacturer advises  ciprofloxacin  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciprofloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926831",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926831_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"clodronate\" outputclass=\"int-drug\">clodronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid antacids for 2 hours before or 1 hour after <ph otherprops=\"clodronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/sodium-clodronate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4681\">clodronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   clodronate .  Manufacturer advises avoid antacids for 2 hours before or 1 hour after  clodronate .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clodronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926832",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926832_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"dasatinib\" outputclass=\"int-drug\">dasatinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   dasatinib .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dasatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926833",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926833_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"deflazacort\" outputclass=\"int-drug\">deflazacort</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   deflazacort .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deflazacort</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926834",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926834_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"delafloxacin\" outputclass=\"int-drug\">delafloxacin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"delafloxacin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/delafloxacin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP221106\">delafloxacin</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   delafloxacin .  Manufacturer advises  delafloxacin  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Delafloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926835",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926835_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"demeclocycline\" outputclass=\"int-drug\">demeclocycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   demeclocycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Demeclocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926836",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926836_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"dexamethasone\" outputclass=\"int-drug\">dexamethasone</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   dexamethasone .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926837",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926837_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"digoxin\" outputclass=\"int-drug\">digoxin</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   digoxin .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Digoxin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926838",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926838_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"dipyridamole\" outputclass=\"int-drug\">dipyridamole</ph> <ph outputclass=\"int-substanceQualifier\">(immediate release tablets)</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   dipyridamole   (immediate release tablets) .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dipyridamole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926839",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926839_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"dolutegravir\" outputclass=\"int-drug\">dolutegravir</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"dolutegravir\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/dolutegravir.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP34479\">dolutegravir</xref></ph> should be taken 2 hours before or 6 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   dolutegravir .  Manufacturer advises  dolutegravir  should be taken 2 hours before or 6 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dolutegravir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926840",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926840_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"doxycycline\" outputclass=\"int-drug\">doxycycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   doxycycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxycycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926841",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926841_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"eltrombopag\" outputclass=\"int-drug\">eltrombopag</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"eltrombopag\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/eltrombopag.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5928\">eltrombopag</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   eltrombopag .  Manufacturer advises  eltrombopag  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eltrombopag</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926842",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926842_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"elvitegravir\" outputclass=\"int-drug\">elvitegravir</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   elvitegravir .  Manufacturer advises separate administration by at least 4 hours .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Elvitegravir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926843",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926843_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"erlotinib\" outputclass=\"int-drug\">erlotinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"erlotinib\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/erlotinib.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5529\">erlotinib</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   erlotinib .  Manufacturer advises  erlotinib  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Erlotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926844",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926844_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"estramustine\" outputclass=\"int-drug\">estramustine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   estramustine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Estramustine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926845",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926845_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"fexofenadine\" outputclass=\"int-drug\">fexofenadine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   fexofenadine .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fexofenadine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926846",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926846_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"gabapentin\" outputclass=\"int-drug\">gabapentin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"gabapentin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/gabapentin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP2930\">gabapentin</xref></ph> should be taken 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   gabapentin .  Manufacturer advises  gabapentin  should be taken 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gabapentin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926847",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926847_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"gefitinib\" outputclass=\"int-drug\">gefitinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   gefitinib .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gefitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926848",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926848_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"gemfibrozil\" outputclass=\"int-drug\">gemfibrozil</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   gemfibrozil .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gemfibrozil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926849",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926849_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"hydroxychloroquine\" outputclass=\"int-drug\">hydroxychloroquine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   hydroxychloroquine .  Manufacturer advises separate administration by at least 4 hours .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroxychloroquine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926850",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926850_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid antacids for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid antacids for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibandronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926851",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926851_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"iron\" outputclass=\"int-drug\">iron</ph>. <ph outputclass=\"int-action\">Manufacturer advises iron should be taken 1 hour before or 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   iron .  Manufacturer advises iron should be taken 1 hour before or 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Iron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926852",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926852_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"itraconazole\" outputclass=\"int-drug\">itraconazole</ph> <ph outputclass=\"int-substanceQualifier\">capsules</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"itraconazole\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/itraconazole.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3702\">itraconazole</xref></ph> should be taken 2 hours before or 1 hour after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   itraconazole   capsules .  Manufacturer advises  itraconazole  should be taken 2 hours before or 1 hour after antacids .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Itraconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926853",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926853_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ketoconazole\" outputclass=\"int-drug\">ketoconazole</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   ketoconazole .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketoconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926854",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926854_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"lapatinib\" outputclass=\"int-drug\">lapatinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   is predicted to   decrease   the absorption of   oral   lapatinib .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lapatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926855",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926855_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ledipasvir\" outputclass=\"int-drug\">ledipasvir</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   ledipasvir .  Manufacturer advises separate administration by 4 hours .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ledipasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926856",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926856_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"levofloxacin\" outputclass=\"int-drug\">levofloxacin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"levofloxacin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/levofloxacin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3668\">levofloxacin</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   levofloxacin .  Manufacturer advises  levofloxacin  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levofloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926857",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926857_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"levomepromazine\" outputclass=\"int-drug\">levomepromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   levomepromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levomepromazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926858",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926858_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"levothyroxine\" outputclass=\"int-drug\">levothyroxine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   levothyroxine .  Manufacturer advises separate administration by at least 4 hours .    \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levothyroxine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926859",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926859_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"lymecycline\" outputclass=\"int-drug\">lymecycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   lymecycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lymecycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926860",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926860_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"minocycline\" outputclass=\"int-drug\">minocycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   minocycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Minocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926861",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926861_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"moxifloxacin\" outputclass=\"int-drug\">moxifloxacin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"moxifloxacin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/moxifloxacin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3671\">moxifloxacin</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   moxifloxacin .  Manufacturer advises  moxifloxacin  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Moxifloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926862",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926862_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"mycophenolate\" outputclass=\"int-drug\">mycophenolate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   mycophenolate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mycophenolate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926863",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926863_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"neratinib\" outputclass=\"int-drug\">neratinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   neratinib .  Manufacturer advises separate administration by at least 3 hours .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neratinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926864",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926864_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">affect</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"nilotinib\" outputclass=\"int-drug\">nilotinib</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   might   affect   the absorption of   oral   nilotinib .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nilotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926865",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926865_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ofloxacin\" outputclass=\"int-drug\">ofloxacin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"ofloxacin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/ofloxacin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3678\">ofloxacin</xref></ph> should be taken 2 hours before or 4 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   ofloxacin .  Manufacturer advises  ofloxacin  should be taken 2 hours before or 4 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ofloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926866",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926866_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"oxytetracycline\" outputclass=\"int-drug\">oxytetracycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   oxytetracycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxytetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926867",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926867_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"pazopanib\" outputclass=\"int-drug\">pazopanib</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"pazopanib\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/pazopanib.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5542\">pazopanib</xref></ph> should be taken 1 hour before or 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   pazopanib .  Manufacturer advises  pazopanib  should be taken 1 hour before or 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "50",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pazopanib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926868",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926868_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"penicillamine\" outputclass=\"int-drug\">penicillamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   penicillamine .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "51",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Penicillamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926869",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926869_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"pericyazine\" outputclass=\"int-drug\">pericyazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   pericyazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "52",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pericyazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926870",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926870_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of metabolic alkalosis when given with</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"polystyrene sulfonate\" outputclass=\"int-drug\">polystyrene sulfonate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   increase   the risk of metabolic alkalosis when given with   oral   polystyrene sulfonate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "53",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Polystyrene sulfonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926871",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926871_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"prochlorperazine\" outputclass=\"int-drug\">prochlorperazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   prochlorperazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "54",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prochlorperazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926872",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926872_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"proguanil\" outputclass=\"int-drug\">proguanil</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   proguanil .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "55",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Proguanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926873",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926873_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"promazine\" outputclass=\"int-drug\">promazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   promazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "56",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Promazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926874",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926874_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"raltegravir\" outputclass=\"int-drug\">raltegravir</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   raltegravir .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "57",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Raltegravir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926875",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926875_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"rifampicin\" outputclass=\"int-drug\">rifampicin</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"rifampicin\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/rifampicin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3619\">rifampicin</xref></ph> should be taken 1 hour before antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   rifampicin .  Manufacturer advises  rifampicin  should be taken 1 hour before antacids .    \n\n"
						}
					],
					"hasOrder": "58",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rifampicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926876",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926876_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"rilpivirine\" outputclass=\"int-drug\">rilpivirine</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"rilpivirine\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/rilpivirine.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP3830\">rilpivirine</xref></ph> should be taken 4 hours before or 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   rilpivirine .  Manufacturer advises  rilpivirine  should be taken 4 hours before or 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "59",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rilpivirine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926877",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926877_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"riociguat\" outputclass=\"int-drug\">riociguat</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"riociguat\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/riociguat.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93590\">riociguat</xref></ph> should be taken 1 hour before or 2 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the exposure to   oral   riociguat .  Manufacturer advises  riociguat  should be taken 1 hour before or 2 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "60",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Riociguat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926878",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926878_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"risedronate\" outputclass=\"int-drug\">risedronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by at least 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   risedronate .  Manufacturer advises separate administration by at least 2 hours .    \n\n"
						}
					],
					"hasOrder": "61",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Risedronate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926879",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926879_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"rosuvastatin\" outputclass=\"int-drug\">rosuvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   rosuvastatin .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "62",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rosuvastatin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926880",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926880_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">Antacids</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"roxadustat\" outputclass=\"int-drug\">roxadustat</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"roxadustat\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/roxadustat.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP223244\">roxadustat</xref></ph> should be taken at least 1 hour after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Antacids   might   decrease   the exposure to   roxadustat .  Manufacturer advises  roxadustat  should be taken at least 1 hour after antacids .    \n\n"
						}
					],
					"hasOrder": "63",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Roxadustat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926881",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926881_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">Antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"selpercatinib\" outputclass=\"int-drug\">selpercatinib</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Antacids   are predicted to   decrease   the exposure to   selpercatinib .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "64",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selpercatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926882",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926882_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"sotorasib\" outputclass=\"int-drug\">sotorasib</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"sotorasib\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/sotorasib.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP223696\">sotorasib</xref></ph> should be taken 4 hours before or 10 hours after antacids</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the exposure to   oral   sotorasib .  Manufacturer advises  sotorasib  should be taken 4 hours before or 10 hours after antacids .    \n\n"
						}
					],
					"hasOrder": "65",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotorasib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926883",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926883_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"strontium\" outputclass=\"int-drug\">strontium</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   strontium .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "66",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Strontium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926884",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926884_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"sulpiride\" outputclass=\"int-drug\">sulpiride</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   sulpiride .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "67",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulpiride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926885",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926885_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-magnitude\">greatly</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"tetracycline\" outputclass=\"int-drug\">tetracycline</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 to 3 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   greatly   decrease   the absorption of   oral   tetracycline .  Manufacturer advises separate administration by 2 to 3 hours .    \n\n"
						}
					],
					"hasOrder": "68",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926886",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926886_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"tipranavir\" outputclass=\"int-drug\">tipranavir</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   tipranavir .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "69",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tipranavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926887",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926887_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"trifluoperazine\" outputclass=\"int-drug\">trifluoperazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   decrease   the absorption of   oral   trifluoperazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "70",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trifluoperazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926888",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926888_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ursodeoxycholic acid\" outputclass=\"int-drug\">ursodeoxycholic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 2 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   ursodeoxycholic acid .  Manufacturer advises separate administration by 2 hours .    \n\n"
						}
					],
					"hasOrder": "71",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ursodeoxycholic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926889",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/antacids-2#bnf_i1643857926889_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-heading-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"velpatasvir\" outputclass=\"int-drug\">velpatasvir</ph>. <ph outputclass=\"int-action\">Manufacturer advises separate administration by 4 hours</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the concentration of   oral   velpatasvir .  Manufacturer advises separate administration by 4 hours .    \n\n"
						}
					],
					"hasOrder": "72",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Velpatasvir</title>"
					}
				}
			],
			"hasSearchLabel": " Antacids  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/antacids-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Antacids </title>"
			},
			"rdfs:label": "antacids"
		}
	]
}